BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33014187
Number of visits today
8090
Number of downloads
16204979
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Stańczak-Mrozek KI, Sobczak A, Lipiński L, Sienkiewicz E, Makarewicz D, Topór-Mądry R, Pinkas J, Sierpiński RA. The Potential Benefits of the Influenza Vaccination on COVID-19 Mortality Rate-A Retrospective Analysis of Patients in Poland. Vaccines (Basel) 2021;10:5. [PMID: 35062666 DOI: 10.3390/vaccines10010005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Hwang JH, You YS, Yeom SW, Lee MG, Lee JH, Kim MG, Kim JS. Influenza viral infection is a risk factor for severe illness in COVID-19 patients: a nationwide population-based cohort study. Emerg Microbes Infect 2023;12:2164215. [PMID: 36580041 DOI: 10.1080/22221751.2022.2164215] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Rzymski P, Sikora D, Zeyland J, Poniedziałek B, Kiedik D, Falfushynska H, Fal A. Frequency and Nuisance Level of Adverse Events in Individuals Receiving Homologous and Heterologous COVID-19 Booster Vaccine. Vaccines 2022;10:754. [DOI: 10.3390/vaccines10050754] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
3 Pietraszek A, Sobieszczańska M, Makuch S, Dróżdż M, Mazur G, Agrawal S. Identification of Barriers Limiting the Use of Preventive Vaccinations against Influenza among the Elderly Population: A Cross-Sectional Analysis. Vaccines 2022;10:651. [DOI: 10.3390/vaccines10050651] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345